Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Oxford Pharm ×

Actualizaciones regulatorias

9 sept 2026•1 min de lectura

FDA Approves Oxford Pharm Generic Simvastatin Tablets (ANDA078735)

FDA has approved Oxford Pharm's abbreviated new drug application for generic simvastatin tablets in five strengths, all prescription oral products.